(Q36303929)

13 August 2017

1 reference

title

Mechanisms of disease: Inflammation and the origins of cancer (English)

1 reference

13 August 2017

0 references

2

Martin J Blaser

1 reference

13 August 2017

Steven F Moss

1

1 reference

13 August 2017

1 February 2005

1 reference

Nature Clinical Practice Oncology

13 August 2017

1 reference

13 August 2017

2

1 reference

13 August 2017

90-7; quiz 1 p following 113

1 reference

13 August 2017

2

1 reference

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

13 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

Proteases, extracellular matrix, and cancer: a workshop of the path B study section

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

Helicobacter pylori persistence: biology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Radical causes of cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Rules for making human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Functional diversity of helper T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Global cancer statistics in the year 2000.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPONC0081

1 reference

7 January 2021

A model for gastric cancer epidemiology

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Control of gut differentiation and intestinal-type gastric carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Helicobacter pylori and gastrointestinal tract adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Helicobacter pylori infection and the development of gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Helicobacter pyloriInfection

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Cellular responses induced after contact with Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Meta-analysis of the relationship between cagA seropositivity and gastric cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Natural variation in populations of persistently colonizing bacteria affect human host cell phenotype

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

The immune response against Helicobacter pylori--a direct linkage to the development of gastroduodenal disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Pattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori-associated antral gastritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells: potential role in CD4+ T cell activation during Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Rapid recurrence of Helicobacter pylori infection in Peruvian patients after successful eradication. Gastrointestinal Physiology Working Group of the Universidad Peruana Cayetano Heredia and The Johns Hopkins University

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Influence of Helicobacter pylori on reactive oxygen-induced gastric epithelial cell injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Helicobacter pylori stimulates host cyclooxygenase-2 gene transcription: critical importance of MEK/ERK-dependent activation of USF1/-2 and CREB transcription factors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Effects of H. pylori infection of gastric epithelial cells on cell cycle control

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Chronic Helicobacter pylori infection induces an apoptosis-resistant phenotype associated with decreased expression of p27(kip1)

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Gastric cancer originating from bone marrow-derived cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Gastric MALT lymphoma: from aetiology to treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Immunoproliferative small intestinal disease associated with Campylobacter jejuni

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Mechanisms of Human Hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

A controlled trial of a human papillomavirus type 16 vaccine

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Vaccination strategies for the treatment and prevention of cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0081

7 January 2021

Identifiers

DOI

10.1038/NCPONC0081

1 reference

13 August 2017

1 reference

PubMed ID

16264881